Variable | Overall survival | Cancer-specific survival | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |||
Location | 0.076 | 0.054 | ||||||
RCC | Referent | Referent | ||||||
LCC | 0.94 | 0.89 | 0.99 | 0.028 | 1.01 | 0.93 | 1.10 | 0.811 |
Rectum | 0.99 | 0.91 | 1.07 | 0.741 | 1.15 | 1.02 | 1.29 | 0.022 |
Age at diagnosis (year) | <0.0001 | <0.0001 | ||||||
≤ 50 | Referent | Referent | ||||||
51–60 | 1.70 | 1.50 | 1.92 | <0.0001 | 1.27 | 1.07 | 1.51 | 0.007 |
61–70 | 2.35 | 2.08 | 2.63 | <0.0001 | 1.35 | 1.15 | 1.58 | <0.0001 |
71–80 | 3.91 | 3.46 | 4.40 | <0.0001 | 1.97 | 1.68 | 2.32 | <0.0001 |
≥ 81 | 7.18 | 6.26 | 8.22 | <0.0001 | 3.23 | 2.68 | 3.91 | <0.0001 |
Stage | <0.0001 | <0.0001 | ||||||
Localized | Referent | Referent | ||||||
Regional | 1.16 | 1.11 | 1.23 | <0.0001 | 1.50 | 1.38 | 1.63 | <0.0001 |
Distant | 2.17 | 1.90 | 2.47 | <0.0001 | 3.72 | 3.15 | 4.39 | <0.0001 |
Unknown | 1.21 | 1.04 | 1.40 | 0.014 | 1.48 | 1.19 | 1.85 | 0.001 |
Grade | 0.949 | 0.491 | ||||||
Grade I | Referent | Referent | ||||||
Grade II | 1.01 | 0.93 | 1.09 | 0.853 | 1.07 | 0.95 | 1.22 | 0.258 |
Grade III | 1.02 | 0.93 | 1.12 | 0.700 | 1.12 | 0.96 | 1.30 | 0.148 |
Unknown | 0.98 | 0.98 | 1.07 | 0.673 | 1.10 | 0.95 | 1.27 | 0.198 |
Race | <0.0001 | <0.0001 | ||||||
White | Referent | Referent | ||||||
Black | 1.24 | 1.13 | 1.36 | <0.0001 | 1.31 | 1.14 | 1.51 | <0.0001 |
Others | 0.94 | 0.85 | 1.04 | 0.223 | 0.84 | 1.80 | 0.99 | 0.038 |
Gender | <0.0001 | <0.0001 | ||||||
Male | Referent | Referent | ||||||
Female | 0.74 | 0.70 | 0.78 | <0.0001 | 0.83 | 0.77 | 0.90 | <0.0001 |
Year of diagnosis | <0.0001 | <0.0001 | ||||||
1973–1985 | Referent | Referent | ||||||
1986–1995 | 1.27 | 1.20 | 1.36 | <0.0001 | 1.24 | 1.13 | 1.36 | <0.0001 |
1996–2005 | 2.07 | 2.91 | 2.51 | <0.0001 | 2.03 | 1.80 | 2.28 | <0.0001 |